995:HKEXAnhui Expressway Company Limited Class H Analysis
Data as of 2026-03-17 - not real-time
HK$2.03
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Linklogis Inc. (9959.HK) trades at HK$2.03, far below its DCF‑derived fair value of HK$8.48, implying a potential upside of roughly 75%. The stock benefits from a massive cash pile of HK$5.4 bn against modest debt of HK$76 m, and generates positive operating and free cash flow despite a recent revenue decline of 9.3% and deeply negative margins.
Technically, the 20‑day SMA (2.09) sits just above the current price, while the 50‑day SMA (2.23) and 200‑day SMA (2.43) remain higher, indicating a short‑term bearish bias. However, the MACD histogram is positive and the MACD signal is flagged as bullish, and the RSI at 44.9 suggests the stock is not yet oversold. Volatility is elevated at over 66% (30‑day) and volume is on a decreasing trend, adding to short‑term risk, while the low beta (~0.15) points to limited systematic market exposure.
Technically, the 20‑day SMA (2.09) sits just above the current price, while the 50‑day SMA (2.23) and 200‑day SMA (2.43) remain higher, indicating a short‑term bearish bias. However, the MACD histogram is positive and the MACD signal is flagged as bullish, and the RSI at 44.9 suggests the stock is not yet oversold. Volatility is elevated at over 66% (30‑day) and volume is on a decreasing trend, adding to short‑term risk, while the low beta (~0.15) points to limited systematic market exposure.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD signal despite bearish SMA positioning
- High short‑term volatility and decreasing volume
- Support level at HK$1.84 offering limited downside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Substantial valuation gap to DCF fair value
- Strong cash position and low leverage
- Potential earnings recovery as margins improve
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic foothold in China supply‑chain finance technology
- Undervalued relative to industry peers and long‑term growth narrative
- Low systematic risk (beta) combined with sizable upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth-9.30%
Profit Margin-98.16%
P/E Ratio96.7
ROE-12.29%
ROA-4.04%
Debt/Equity1.03
P/B Ratio0.5
Op. Cash FlowHK$773.3M
Free Cash FlowHK$860.9M
Industry P/E34.4
Technical Analysis
TrendBearish
RSI44.9
SupportHK$1.84
ResistanceHK$2.31
MA 20HK$2.09
MA 50HK$2.23
MA 200HK$2.43
MACDBullish
VolumeDecreasing
Fear & Greed Index81.48
Valuation
Fair ValueHK$8.48
Target PriceHK$3.55
Upside/Downside74.88%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.15
Volatility66.25%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.